NCT04458922 2026-03-17Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced ChondrosarcomaNational Cancer Institute (NCI)Phase 2 Active not recruiting27 enrolled 16 charts
NCT03132155 2024-05-24QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell SarcomaNantPharma, LLCPhase 2 Terminated8 enrolled 10 charts